The present invention includes compounds that are useful in perturbing or disrupting the function of a transmembrane or intracellular protein, whereby binding of a compound to the transmembrane or intracellular protein induces proteasomal degradation of the transmembrane or intracellular protein. The present invention further includes a method of inducing proteasomal degradation of a transmembrane or intracellular protein. The present invention further includes a method of identifying or validating a protein of interest as a therapeutic target for treatment of a disease state or condition.
本发明包括一些化合物,这些化合物有助于扰乱或破坏跨膜或胞内蛋白的功能,其中化合物与跨膜或胞内蛋白的结合诱导跨膜或胞内蛋白的
蛋白酶体降解。本发明还包括一种诱导跨膜或胞内蛋白的
蛋白酶体降解的方法。本发明还包括一种鉴定或验证感兴趣蛋白作为治疗疾病状态或病情的治疗靶点的方法。